These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 31541762)

  • 21. The PD-1/PD-L1 inhibitory pathway is altered in pre-eclampsia and regulates T cell responses in pre-eclamptic rats.
    Tian M; Zhang Y; Liu Z; Sun G; Mor G; Liao A
    Sci Rep; 2016 Jun; 6():27683. PubMed ID: 27277012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Andrographolide exerts anti-inflammatory effects in Mycobacterium tuberculosis-infected macrophages by regulating the Notch1/Akt/NF-κB axis.
    He W; Sun J; Zhang Q; Li Y; Fu Y; Zheng Y; Jiang X
    J Leukoc Biol; 2020 Dec; 108(6):1747-1764. PubMed ID: 32991757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PD-L1 induces macrophage polarization toward the M2 phenotype via Erk/Akt/mTOR.
    Wei Y; Liang M; Xiong L; Su N; Gao X; Jiang Z
    Exp Cell Res; 2021 May; 402(2):112575. PubMed ID: 33771483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy.
    Qian J; Wang C; Wang B; Yang J; Wang Y; Luo F; Xu J; Zhao C; Liu R; Chu Y
    J Neuroinflammation; 2018 Oct; 15(1):290. PubMed ID: 30333036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory cytokines IL-17 and TNF-α up-regulate PD-L1 expression in human prostate and colon cancer cells.
    Wang X; Yang L; Huang F; Zhang Q; Liu S; Ma L; You Z
    Immunol Lett; 2017 Apr; 184():7-14. PubMed ID: 28223102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PD-L1 regulates cell proliferation and apoptosis in acute myeloid leukemia by activating PI3K-AKT signaling pathway.
    Wang F; Yang L; Xiao M; Zhang Z; Shen J; Anuchapreeda S; Tima S; Chiampanichayakul S; Xiao Z
    Sci Rep; 2022 Jul; 12(1):11444. PubMed ID: 35794161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of baricitinib in regulating programmed death 1 and ligand programmed cell death ligand 1 through JAK/STAT pathway in psoriasis.
    Deepak HB; Prince SE; Deshpande P
    Indian J Pharmacol; 2022; 54(3):183-193. PubMed ID: 35848689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Licochalcone A inhibits interferon-gamma-induced programmed death-ligand 1 in lung cancer cells.
    Yuan LW; Jiang XM; Xu YL; Huang MY; Chen YC; Yu WB; Su MX; Ye ZH; Chen X; Wang Y; Lu JJ
    Phytomedicine; 2021 Jan; 80():153394. PubMed ID: 33130472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitric oxide modulates interleukin-1beta and tumour necrosis factor-alpha synthesis, and disease regression by alveolar macrophages in pulmonary tuberculosis.
    Wang CH; Kuo HP
    Respirology; 2001 Mar; 6(1):79-84. PubMed ID: 11264769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Control of PD-L1 Expression by Oncogenic Activation of the AKT-mTOR Pathway in Non-Small Cell Lung Cancer.
    Lastwika KJ; Wilson W; Li QK; Norris J; Xu H; Ghazarian SR; Kitagawa H; Kawabata S; Taube JM; Yao S; Liu LN; Gills JJ; Dennis PA
    Cancer Res; 2016 Jan; 76(2):227-38. PubMed ID: 26637667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baicalin attenuates PD-1/PD-L1 axis-induced immunosuppression in piglets challenged with Glaesserella parasuis by inhibiting the PI3K/Akt/mTOR and RAS/MEK/ERK signalling pathways.
    Fu S; Li J; You J; Liu S; Dong Q; Fu Y; Luo R; Sun Y; Tian X; Liu W; Zhang J; Ding Y; Zhang Y; Wang W; Guo L; Qiu Y
    Vet Res; 2024 Jul; 55(1):95. PubMed ID: 39075562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PD-1/PD-L1 inhibition promotes hepatic regeneration in small-for-size liver following extended hepatectomy.
    Yan X; Shi JH; Xue JF; Guo WZ; Li B; Zhang SJ
    Cytokine; 2022 Nov; 159():156017. PubMed ID: 36054963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kallikrein 12 Regulates Innate Resistance of Murine Macrophages against
    Sabir N; Hussain T; Liao Y; Wang J; Song Y; Shahid M; Cheng G; Mangi MH; Yao J; Yang L; Zhao D; Zhou X
    Cells; 2019 May; 8(5):. PubMed ID: 31060300
    [No Abstract]   [Full Text] [Related]  

  • 34. Hepatitis B virus-triggered PTEN/β-catenin/c-Myc signaling enhances PD-L1 expression to promote immune evasion.
    Sun Y; Yu M; Qu M; Ma Y; Zheng D; Yue Y; Guo S; Tang L; Li G; Zheng W; Wang M; Guo D; Li C
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G162-G173. PubMed ID: 31604033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EBV-associated gastric cancer evades T-cell immunity by PD-1/PD-L1 interactions.
    Sasaki S; Nishikawa J; Sakai K; Iizasa H; Yoshiyama H; Yanagihara M; Shuto T; Shimokuri K; Kanda T; Suehiro Y; Yamasaki T; Sakaida I
    Gastric Cancer; 2019 May; 22(3):486-496. PubMed ID: 30264329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PD-L1 Status in Gastric Cancers, Association with the Transcriptional, Growth Factors, AKT/mTOR Components Change, and Autophagy Initiation.
    Spirina L; Avgustinovich A; Afanas'ev S; Volkov M; Dobrodeev A; Cheremisina O; Kostromitsky D
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blockade of the PD-1/PD-L1 Immune Checkpoint Pathway Improves Infection Outcomes and Enhances Fungicidal Host Defense in a Murine Model of Invasive Pulmonary Mucormycosis.
    Wurster S; Albert ND; Bharadwaj U; Kasembeli MM; Tarrand JJ; Daver N; Kontoyiannis DP
    Front Immunol; 2022; 13():838344. PubMed ID: 35251033
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Woo M; Wood C; Kwon D; Park KP; Fejer G; Delorme V
    Front Immunol; 2018; 9():438. PubMed ID: 29593716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The blockade of PD-1/PD-L1 pathway promotes the apoptosis of CD19
    Wang Z; Tan F
    Scand J Immunol; 2020 Feb; 91(2):e12836. PubMed ID: 31598989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-6 Signaling Blockade during CD40-Mediated Immune Activation Favors Antitumor Factors by Reducing TGF-β, Collagen Type I, and PD-L1/PD-1.
    Eriksson E; Milenova I; Wenthe J; Moreno R; Alemany R; Loskog A
    J Immunol; 2019 Feb; 202(3):787-798. PubMed ID: 30617223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.